Quarterly report · Q1

Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥1.3bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥5.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥119m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥154m2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥135m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥639m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥178m2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥135m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥231m2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥110m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥469m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥161m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥110m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥161m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥9.4bnat 2023-06-30Cons.Assets
Total assets¥9.3bnat 2023-03-31Cons.Assets
Total assets¥9.5bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥3.6bnat 2023-06-30Cons.Liabilities
Total liabilities¥3.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥5.9bnat 2023-06-30Cons.Net assets
Net assets / equity¥5.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥5.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥2.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥39.572023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥169.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.322022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.4%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio57.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥361m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥361m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥323,000
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥30m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥929m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥929m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥170m
—segment totalrevenue2023-04-01 → 2023-06-30¥1.3bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥1.3bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥323,000
—segment totalsegment profit2023-04-01 → 2023-06-30¥200m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥323,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥200m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥353m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥352m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥25m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥981m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥981m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥199m
—segment totalrevenue2022-04-01 → 2022-06-30¥1.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥1.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥1m
—segment totalsegment profit2022-04-01 → 2022-06-30¥224m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥224m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 362
ItemContextValueUnit
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember199035000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember24830000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember223865000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember223865000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember929330000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember360838000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember1290169000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1290169000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember323000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember323000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember323000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember929330000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember361161000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember1290492000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1290492000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember170204000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember29994000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember200199000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember200199000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第139期第1四半期(自 2023年4月1日 至 2023年6月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)オーベクス株式会社
Company name in english cover pageFilingDateInstantAuBEX CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 栗 原 則 義
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00584
Fund codeFilingDateInstant-
Security codeFilingDateInstant35830
Filer name in japaneseFilingDateInstant
Original text (Japanese)オーベクス株式会社
Filer name in englishFilingDateInstantAuBEX CORPORATION
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Current fiscal year start dateFilingDateInstant2023-04-01
Current period end dateFilingDateInstant2023-06-30

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass